Surprisingly, the addition of autologous T cells inhibited expression of CD206, CD163, and CD16 in tri-cultured melanoma-conditioned macrophages irrespective of CDDO-Me treatment (Figures 1B–D). The gene discussed is MRC1; the disease is melanoma.